Ascletis Pharma (01672) Announces 69.256 Million New Shares Issued and Provides Share Repurchase Update

Bulletin Express02-10 18:24

On 10 February 2026, Ascletis Pharma Inc. announced the placement of 69,256,000 new ordinary shares under a general mandate at HKD 12.18 per share. This issuance represents 6.98% of the existing share capital, increasing the total number of issued shares (excluding treasury shares) from 991,874,320 to 1,061,130,320. Including 7,084,210 treasury shares, the total number of shares in issue reached 1,068,214,530 as of 10 February 2026.

The announcement also disclosed share repurchases for cancellation that took place from 3 April 2025 to 31 December 2025, totaling 5,786,000 shares. These transactions occurred at various prices ranging from HKD 4.8531 to HKD 14.5794. The repurchased shares had not been cancelled as of the closing balance date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131639772?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 18:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131639772","market":"hk","top_or_hot":-1,"title":"Ascletis Pharma (01672) Announces 69.256 Million New Shares Issued and Provides Share Repurchase Update","media":"Bulletin Express","content":"<p>On 10 February 2026, Ascletis Pharma Inc. announced the placement of 69,256,000 new ordinary shares under a general mandate at HKD 12.18 per share. This issuance represents 6.98% of the existing share capital, increasing the total number of issued shares (excluding treasury shares) from 991,874,320 to 1,061,130,320. Including 7,084,210 treasury shares, the total number of shares in issue reached 1,068,214,530 as of 10 February 2026.</p>\n<p>The announcement also disclosed share repurchases for cancellation that took place from 3 April 2025 to 31 December 2025, totaling 5,786,000 shares. These transactions occurred at various prices ranging from HKD 4.8531 to HKD 14.5794. The repurchased shares had not been cancelled as of the closing balance date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ascletis Pharma (01672) Announces 69.256 Million New Shares Issued and Provides Share Repurchase Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAscletis Pharma (01672) Announces 69.256 Million New Shares Issued and Provides Share Repurchase Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-10 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 10 February 2026, Ascletis Pharma Inc. announced the placement of 69,256,000 new ordinary shares under a general mandate at HKD 12.18 per share. This issuance represents 6.98% of the existing share capital, increasing the total number of issued shares (excluding treasury shares) from 991,874,320 to 1,061,130,320. Including 7,084,210 treasury shares, the total number of shares in issue reached 1,068,214,530 as of 10 February 2026.</p>\n<p>The announcement also disclosed share repurchases for cancellation that took place from 3 April 2025 to 31 December 2025, totaling 5,786,000 shares. These transactions occurred at various prices ranging from HKD 4.8531 to HKD 14.5794. The repurchased shares had not been cancelled as of the closing balance date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01672","symbol_name":"歌礼制药-B","start_time":0,"source_url":"","article_id":"1131639772","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131639772","pubTimestamp":1770719053,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 10 February 2026, Ascletis Pharma Inc. announced the placement of 69,256,000 new ordinary shares under a general mandate at HKD 12.18 per share. This issuance represents 6.98% of the existing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01672":"歌礼制药-B"},"translate_title":"歌礼制药(01672)公布发行6925.6万股新股并提供股份购回更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01672":1},"content_text":"On 10 February 2026, Ascletis Pharma Inc. announced the placement of 69,256,000 new ordinary shares under a general mandate at HKD 12.18 per share. This issuance represents 6.98% of the existing share capital, increasing the total number of issued shares (excluding treasury shares) from 991,874,320 to 1,061,130,320. Including 7,084,210 treasury shares, the total number of shares in issue reached 1,068,214,530 as of 10 February 2026.\nThe announcement also disclosed share repurchases for cancellation that took place from 3 April 2025 to 31 December 2025, totaling 5,786,000 shares. These transactions occurred at various prices ranging from HKD 4.8531 to HKD 14.5794. The repurchased shares had not been cancelled as of the closing balance date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131639772","isCrawlerRequest":true}